N-terminal Pro B-type Natriuretic Peptide Levels: Correlation with Echocardiographically Determined Left Ventricular Diastolic Function in an Ambulatory Cohort

The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients

“…As recently reported by Furumoto et al a close correlation between NT-proBNP levels and color M-Mode derived index of LV filling pressure, but not with BNP was supported our results [21]. Dong et al also reported that clinically stable, ambulatory cohort of patients with cardiovascular disease that exhibited a wide range of LV systolic and diastolic dysfunction showed that both E 0 and E/E 0 ratio correlated significantly with plasma NT-proBNP levels [22]. These recent reports parallel to our findings that examined the effect of LV filling pressures on plasma NT-proBNP levels are increased not only in systolic dysfunction but also even in mild to moderate diastolic dysfunction.…”

Early Markers of Cardiovascular Dysfunction in Young Girls Affected by Cushing's Syndrome before and after Successful Cure

“…Further studies performed in adulthood have confirmed a similar accuracy of NT-proBNP in detecting an isolated diastolic dysfunction related to that revealed by TDI parameters, and by cardiac catheterization techniques [38][39][40] . In our study, significantly higher NT-proBNP levels in female CS patients after surgery were detected, even at a very young age, compared to C.…”

Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency

“…It is currently accepted that one of the most useful tests for evaluating the status of patients with CHF is NTproBNP, not only for systolic but also for diastolic LV dysfunction (11,24). A single measurement of NT-proBNP in patients with advanced CHF can help to identify patients who are at a higher risk of death, and, in one study, it was an even better prognostic marker than anemia (25).…”